Longfei Lin

3.2k total citations · 3 hit papers
76 papers, 2.4k citations indexed

About

Longfei Lin is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Longfei Lin has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Plant Science and 15 papers in Pharmacology. Recurrent topics in Longfei Lin's work include Phytochemistry and biological activity of medicinal plants (11 papers), Pharmacological Effects of Natural Compounds (8 papers) and Natural product bioactivities and synthesis (8 papers). Longfei Lin is often cited by papers focused on Phytochemistry and biological activity of medicinal plants (11 papers), Pharmacological Effects of Natural Compounds (8 papers) and Natural product bioactivities and synthesis (8 papers). Longfei Lin collaborates with scholars based in China, United States and Macao. Longfei Lin's co-authors include Jian Ni, Yuling Liu, Xingbin Yin, Xuechun Li, Changhai Qu, Lei Yan, Hongmei Lin, Sali Cao, Xiaoxv Dong and Jing Fu and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Hazardous Materials and Food Chemistry.

In The Last Decade

Longfei Lin

68 papers receiving 2.3k citations

Hit Papers

Emodin: A Review of its Pharmacology, Toxicity and Pharma... 2014 2026 2018 2022 2016 2014 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longfei Lin China 19 776 691 495 274 219 76 2.4k
Mohammad Raish Saudi Arabia 38 993 1.3× 537 0.8× 663 1.3× 256 0.9× 525 2.4× 192 4.1k
Nemat Ali Saudi Arabia 29 961 1.2× 386 0.6× 518 1.0× 273 1.0× 265 1.2× 201 3.2k
Tareq Abu‐Izneid Pakistan 21 1.2k 1.6× 538 0.8× 272 0.5× 246 0.9× 329 1.5× 57 3.3k
Summya Rashid India 31 1.1k 1.4× 383 0.6× 548 1.1× 345 1.3× 295 1.3× 120 3.2k
Mohammed Abdullah Alshawsh Malaysia 26 777 1.0× 434 0.6× 399 0.8× 142 0.5× 181 0.8× 100 2.1k
Xiaoxv Dong China 27 1.0k 1.3× 805 1.2× 518 1.0× 136 0.5× 317 1.4× 63 2.9k
Amjad Ali Khan Saudi Arabia 36 1.2k 1.6× 616 0.9× 300 0.6× 223 0.8× 284 1.3× 89 3.5k
Abdul Quaiyoom Khan Qatar 34 1.3k 1.7× 474 0.7× 460 0.9× 451 1.6× 265 1.2× 66 3.1k
Xiangchun Shen China 29 1.3k 1.6× 406 0.6× 384 0.8× 247 0.9× 285 1.3× 200 2.9k
Syam Mohan Saudi Arabia 34 1.1k 1.4× 825 1.2× 458 0.9× 156 0.6× 508 2.3× 146 3.4k

Countries citing papers authored by Longfei Lin

Since Specialization
Citations

This map shows the geographic impact of Longfei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longfei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longfei Lin more than expected).

Fields of papers citing papers by Longfei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longfei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longfei Lin. The network helps show where Longfei Lin may publish in the future.

Co-authorship network of co-authors of Longfei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Longfei Lin. A scholar is included among the top collaborators of Longfei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longfei Lin. Longfei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Longfei, et al.. (2025). Exploration of a modified pretreatment process coupled with GC-MS/MS for determination of 18 phthalates in edible oils. Analytical Methods. 17(12). 2607–2615. 1 indexed citations
3.
Zhong, Meng, Wei Zou, Q.P. Cao, et al.. (2025). Differentiation of Citri Reticulatae Pericarpium varieties via HPLC fingerprinting of polysaccharides combined with machine learning. Food Chemistry. 473. 143053–143053.
6.
Zhang, Fan, Longfei Lin, Zhixin Wang, & Hui Li. (2025). Evaluation, correction and masking methods for unpleasant tastes of drugs: A comprehensive review. International Journal of Pharmaceutics. 683. 126008–126008.
7.
Liu, Yuling, et al.. (2024). Prenylated Flavonoids in Sophora flavescens: A Systematic Review of Their Phytochemistry and Pharmacology. The American Journal of Chinese Medicine. 52(4). 1087–1135. 5 indexed citations
8.
Lin, Longfei, et al.. (2024). Research on the anti-aging mechanisms of Panax ginseng extract in mice: a gut microbiome and metabolomics approach. Frontiers in Pharmacology. 15. 1415844–1415844. 9 indexed citations
9.
Yang, Jiapei, Jiaxuan Zhao, Chenwei Jiang, et al.. (2024). Advances in local drug delivery technologies for improved rheumatoid arthritis therapy. Advanced Drug Delivery Reviews. 209. 115325–115325. 19 indexed citations
10.
Lv, Dan, et al.. (2024). Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers. Drug Design Development and Therapy. Volume 18. 1997–2020. 5 indexed citations
11.
Lin, Longfei, et al.. (2024). Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa. International Journal of Nanomedicine. Volume 19. 9843–9870. 11 indexed citations
12.
Liao, Qian, et al.. (2023). The application of computer simulation in biomedical hydrogels research: A review. Journal of Molecular Liquids. 394. 123726–123726. 2 indexed citations
13.
Liu, Yuling, Xin Nie, Longfei Lin, et al.. (2023). Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment. International Journal of Nanomedicine. Volume 18. 5457–5472. 9 indexed citations
14.
Zhang, Fangbo, Feifei Guo, Yi Zhang, et al.. (2022). Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19. Phytomedicine. 109. 154549–154549. 16 indexed citations
15.
Liu, Yuling, Guolin Shi, Yuting Luo, et al.. (2022). Preparation of Polydopamine Modified Celastrol Nanosuspension and its Anti-Liver Cancer Activity in Vitro. SSRN Electronic Journal. 3 indexed citations
16.
Shi, Guolin, Longfei Lin, Yuling Liu, et al.. (2021). Pharmaceutical application of multivariate modelling techniques: a review on the manufacturing of tablets. RSC Advances. 11(14). 8323–8345. 21 indexed citations
18.
Lin, Longfei, Lei Yan, Yuling Liu, et al.. (2019). Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. Journal of Hematology & Oncology. 12(1). 96–96. 142 indexed citations
19.
Zhang, Miao, Lin Guo, Longfei Lin, et al.. (2018). Absorption Characteristics of Combination Medication of Realgar and Indigo Naturalis: In Vitro Transport across MDCK‐MDR1 Cells and In Vivo Pharmacokinetics in Mice after Oral Administration. Evidence-based Complementary and Alternative Medicine. 2018(1). 6493630–6493630. 6 indexed citations
20.
Lin, Longfei, Hui Li, Hongmei Lin, et al.. (2017). Application of iTRAQ-Based Quantitative Proteomics Approach to Identify Deregulated Proteins Associated with Liver Toxicity Induced by Polygonum Multiflorum in Rats. Cellular Physiology and Biochemistry. 43(5). 2102–2116. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026